Initial experience of temperature-controlled irrigated radiofrequency ablation for ischaemic cardiomyopathy ventricular tachycardia ablation
- PMID: 35192098
- PMCID: PMC10066113
- DOI: 10.1007/s10840-022-01158-4
Initial experience of temperature-controlled irrigated radiofrequency ablation for ischaemic cardiomyopathy ventricular tachycardia ablation
Abstract
Background: The DiamondTemp ablation (DTA) catheter system delivers high power, open-irrigated, temperature-controlled radiofrequency (RF) ablation. This novel ablation system has not been previously used for ventricular tachycardia (VT) ablation.
Objective: Feasibility of using the DTA catheter system for VT ablation in ischaemic cardiomyopathy (ICM) patients.
Method: Ten ICM patients with optimal anti-arrhythmic drug therapy and implantable cardiac defibrillators (ICD) were recruited. VT inducibility testing was performed at the end of the procedure. ICD data for device detected VT episodes and device treated VT episodes were collected for 6-months pre- and post-ablation.
Results: Substrate analysis demonstrated reductions in the borderzone area of 4.4 cm2 (p = 0.026) and late potential area of 3.5 cm2 (p = 0.0449) post-ablation, with reductions in the mean bipolar and unipolar voltages of the ablation target areas (0.14 mV (p = 0.0007); 0.59 mV (p = 0.0072) respectively). Complete procedural success was achieved in 9 procedures. Post-ablation VT inducibility testing was not performed in 1 procedure due to a steam pop complication resulting in pericardial tamponade requiring drainage. Mean follow-up of 214 ± 33 days revealed an 88% reduction in total VT episodes (n = 266 median 16 [IQR 3-57] to n = 33 median 0; p = 0.0164) and 77% reduction in ICD therapies (n = 128 median 5 [IQR 2-15] to n = 30 median 0; p = 0.0181).
Conclusion: The DTA system resulted in adequate lesion characteristics with effective substrate modification, acute procedural success and improved outcomes at intermediate-term follow-up. Randomised controlled trials are required to compare the performance of the DTA system against conventional ablation catheters.
Keywords: Feasibility; Ischaemic cardiomyopathy; Temperature-controlled irrigated radiofrequency ablation; Ventricular tachycardia.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Catheter Ablation for Ventricular Tachycardia in Ischaemic Versus Non-Ischaemic Cardiomyopathy: A Systematic Review and Meta-Analysis.Heart Lung Circ. 2022 Aug;31(8):1064-1074. doi: 10.1016/j.hlc.2022.02.014. Epub 2022 May 25. Heart Lung Circ. 2022. PMID: 35643798
-
Catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: Impact of concomitant amiodarone therapy on short- and long-term clinical outcomes.Heart Rhythm. 2021 Jun;18(6):885-893. doi: 10.1016/j.hrthm.2021.02.010. Epub 2021 Feb 13. Heart Rhythm. 2021. PMID: 33592323
-
Impact of substrate-based ablation for ventricular tachycardia in patients with frequent appropriate implantable cardioverter-defibrillator therapy and dilated cardiomyopathy: Long-term experience with high-density mapping.Rev Port Cardiol (Engl Ed). 2021 Nov;40(11):865-873. doi: 10.1016/j.repce.2021.11.006. Rev Port Cardiol (Engl Ed). 2021. PMID: 34857160
-
Epicardial ventricular tachycardia in ischemic cardiomyopathy: Prevalence, electrophysiological characteristics, and long-term ablation outcomes.J Cardiovasc Electrophysiol. 2018 Nov;29(11):1530-1539. doi: 10.1111/jce.13739. Epub 2018 Oct 8. J Cardiovasc Electrophysiol. 2018. PMID: 30230120
-
Outcome of catheter ablation for ventricular tachycardia in patients with ischemic cardiomyopathy: A systematic review and meta-analysis of randomized clinical trials.Int J Cardiol. 2018 Sep 15;267:107-113. doi: 10.1016/j.ijcard.2018.03.127. Epub 2018 Apr 8. Int J Cardiol. 2018. PMID: 29655948
Cited by
-
First experience of temperature-controlled bipolar radiofrequency ablation of ventricular tachycardia originating from the anterior left ventricle using a diamond-embedded-tip catheter.HeartRhythm Case Rep. 2023 May 18;9(8):529-533. doi: 10.1016/j.hrcr.2023.05.003. eCollection 2023 Aug. HeartRhythm Case Rep. 2023. PMID: 37614391 Free PMC article. No abstract available.
-
Detailed analysis of electrogram peak frequency to guide ventricular tachycardia substrate mapping.Europace. 2024 Oct 3;26(10):euae253. doi: 10.1093/europace/euae253. Europace. 2024. PMID: 39343730 Free PMC article.
-
First clinical experience using the DiamondTemp catheter and a novel omnipolar high-resolution mapping system for atrial fibrillation ablation.Cardiol J. 2023;30(1):36-43. doi: 10.5603/CJ.a2022.0122. Epub 2023 Jan 2. Cardiol J. 2023. PMID: 36588311 Free PMC article.
-
Characterizing lesion morphology of a novel diamond-tip temperature-controlled irrigated radiofrequency ablation catheter.J Interv Card Electrophysiol. 2024 Mar;67(2):293-301. doi: 10.1007/s10840-023-01595-9. Epub 2023 Jun 21. J Interv Card Electrophysiol. 2024. PMID: 37344624 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical